Danish Beverage Stock News

cBrain A/S ( CPH:CBRAIN ), might not be a large cap stock, but it received a lot of attention from a substantial price...

DSV recently opened its largest European Contract Logistics facility at Logistics Park Moerdijk in the Netherlands, offering more than 240,000 m² of warehouse and distribution capacity with flexible fulfilment capabilities. The site’s design, featuring over 12,000 solar panels and targeting a BREEAM Excellent certification, highlights how DSV is embedding sustainability into large-scale logistics infrastructure. We will now examine how this large, sustainability-focused Moerdijk facility...

Why Titan Prime’s FDA approval matters for Coloplast (CPSE:COLO B) Coloplast (CPSE:COLO B) has just secured FDA approval for Titan Prime, its next generation inflatable penile prosthesis. This opens a new chapter for the company’s urology portfolio in the U.S. market. The device targets severe erectile dysfunction with a Bioflex polymer design, aiming for strength, durability and comfort in long term implants. For investors, this regulatory milestone raises fresh questions about Coloplast’s...

Wondering if A.P. Møller - Mærsk at around kr.17,815 is offering fair value today, or if the market is missing something in the stock. The share price performance has been strong lately, with returns of 14.9% over the past week, 15.6% over the past month, 21.3% year to date and 53.2% over the last year. Recent headlines around global shipping capacity, freight rates and trade flows have kept attention on container companies like A.P. Møller - Mærsk. These themes help frame how investors are...

Last week saw the newest second-quarter earnings release from Per Aarsleff Holding A/S ( CPH:PAAL B ), an important...

GN Store Nord (CPSE:GN) has drawn fresh attention after BlueParrott, part of the group, introduced its Pro Series Bluetooth headsets for long haul truck drivers, pairing AI powered voice isolation with active noise cancellation. See our latest analysis for GN Store Nord. The launch of the BlueParrott Pro Series comes as GN Store Nord’s share price sits at DKK97.52, with a 7 day share price return of 3.63% but a year to date share price decline of 11.26%. The 5 year total shareholder return is...

Readers hoping to buy TORM plc ( CPH:TRMD A ) for its dividend will need to make their move shortly, as the stock is...

It's been a good week for TCM Group A/S ( CPH:TCM ) shareholders, because the company has just released its latest...

Bavarian Nordic (CPSE:BAVA) received a major contract extension from the US government’s BARDA for its JYNNEOS smallpox vaccine. The extension secures remaining JYNNEOS doses and includes an additional US$97 million commitment for further vaccine supply. The agreement supports a shift to a freeze dried formulation designed for longer shelf life and stockpile use. The company has updated its 2026 revenue and business guidance following the new BARDA commitments. For investors looking at...

Investors may be wondering whether Vestas Wind Systems, at a recent price of DKK194.60, still offers value or if most of the opportunity is already priced in. The stock has returned 1.9% over the last 7 days, 1.6% over the last 30 days, 8.9% year to date, and 92.8% over the past year. Returns over the past 3 and 5 years show declines of 1.8% and 17.5% respectively. Recent headlines around Vestas Wind Systems have focused on the company as a key listed player in the global wind sector. This...

We wouldn't blame TORM plc ( CPH:TRMD A ) shareholders if they were a little worried about the fact that Jacob...

Shareholders appeared unconcerned with Coloplast A/S' ( CPH:COLO B ) lackluster earnings report last week. Our analysis...

As Europe's major indices experience a downturn amid rising geopolitical tensions and inflationary pressures, investors are seeking opportunities in less conventional areas of the market. Penny stocks, often associated with smaller or newer companies, remain an intriguing option despite their somewhat outdated moniker. These stocks can offer growth potential at lower price points when backed by strong financials and solid fundamentals.

As European markets navigate geopolitical tensions and inflationary pressures, the pan-European STOXX Europe 600 Index recently experienced a slight decline, reflecting broader economic challenges. In this environment, dividend stocks can offer investors a potential source of income and stability by providing regular payouts even when market conditions are uncertain.

The subdued market reaction suggests that Solar A/S' ( CPH:SOLAR B ) recent earnings didn't contain any surprises. We...

Bavarian Nordic (CPSE:BAVA) has opened 2026 with Q1 revenue of DKK 1,057.8 million and Basic EPS of DKK 0.20, while the trailing twelve months show revenue of DKK 5.96 billion and Basic EPS of DKK 14.86. This sets a clear snapshot of the current run rate. Over recent quarters, revenue has moved from DKK 2,093.9 million in Q4 2024 to DKK 1,346.6 million in Q1 2025 and DKK 1,057.8 million in Q1 2026. Basic EPS shifted from DKK 10.15 to DKK 2.70 and then DKK 0.20. The latest release therefore...

Last week saw the newest half-year earnings release from Coloplast A/S ( CPH:COLO B ), an important milestone in the...

TORM, ticker CPSE:TRMD A, reported a strong Q1 2026 earnings surge. Geopolitical tensions and the closure of the Strait of Hormuz pushed freight rates to record highs. The company upgraded full year guidance and moved ahead with a fleet renewal plan, adding new vessels. TORM focuses on product tankers that transport refined oil products, so freight disruptions and route changes directly affect its earnings power. With key shipping lanes constrained and rerouted, demand for available,...

Investors were disappointed with the weak earnings posted by Netcompany Group A/S ( CPH:NETC ). While the headline...

Unsurprisingly, Zealand Pharma A/S' ( CPH:ZEAL ) stock price was strong on the back of its healthy earnings report. We...

Coloplast (CPSE:COLO B) Q2 2026 earnings in focus Coloplast (CPSE:COLO B) has kicked off its Q2 2026 reporting with Q1 figures that put hard numbers around the story, with revenue at about DKK7.0 billion, basic EPS of DKK6.21 and net income of DKK1.40 billion. These results are backed by trailing 12 month totals of DKK27.9 billion in revenue, DKK17.70 in EPS and DKK4.0 billion in net income. Over recent quarters the company has seen revenue hover in a tight band between DKK6.93 billion and...

We wouldn't blame Dampskibsselskabet Norden A/S ( CPH:DNORD ) shareholders if they were a little worried about the fact...

A week ago, Zealand Pharma A/S ( CPH:ZEAL ) came out with a strong set of first-quarter numbers that could potentially...

We wouldn't blame Danske Bank A/S ( CPH:DANSKE ) shareholders if they were a little worried about the fact that Carsten...